What dose of olanzapine long‑acting injection (Zyprexa Relprevv) is equivalent to 5–10 mg of oral olanzapine daily?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Olanzapine Long-Acting Injection Dose Equivalence to 5-10 mg Oral Olanzapine

For patients taking 5-10 mg of oral olanzapine daily, the equivalent dose of Zyprexa Relprevv (olanzapine long-acting injection) is 150 mg every 2 weeks or 210 mg every 4 weeks.

Dose Conversion Recommendations

For 10 mg/day Oral Olanzapine

  • 150 mg every 2 weeks is the recommended starting dose 1
  • Alternatively, 210 mg every 4 weeks can be used 1
  • The 405 mg every 4 weeks dose produces comparable relapse risk to remaining on 10 mg/day oral (HR=1.03) 1

For 5 mg/day Oral Olanzapine

  • 150 mg every 2 weeks provides mean steady-state concentrations similar to oral 5-10 mg/day 2
  • This lower oral dose range corresponds to the minimum therapeutic LAI dosing 2

Pharmacokinetic Considerations

Direct switching from oral to LAI is feasible without oral supplementation or bridging therapy 1. The LAI formulation demonstrates:

  • Immediate olanzapine concentrations upon injection 3
  • Half-life of approximately 30 days (controlled by slow intramuscular absorption) 3
  • Steady-state achievement after approximately 3 months 3
  • Average steady-state concentrations for 150 mg every 2 weeks: 16-32 ng/mL (10th-90th percentile) 3

Clinical Evidence

A 24-week randomized study demonstrated that patients stabilized on 10 mg/day oral olanzapine who switched directly to 405 mg every 4 weeks had relapse rates comparable to continuing oral therapy 1. The study showed relapse rates for therapeutic LAI doses (≥150 mg) varied from 1.5% to 18.8% depending on the prior oral dose and LAI dose selected 1.

Trough concentrations remain above the lower therapeutic range even at the first injection, eliminating concerns about subtherapeutic levels during the transition period 3.

Dosing Algorithm

  1. If currently on 10 mg/day oral: Initiate 150 mg every 2 weeks OR 210 mg every 4 weeks 1
  2. If currently on 5 mg/day oral: Initiate 150 mg every 2 weeks 2
  3. No oral supplementation required during transition 1
  4. Monitor for 3 months to reach steady-state 3

Safety Profile

The LAI formulation carries the same adverse effect profile as oral olanzapine, with the addition of injection site-related events 2. Common adverse events include injection site pain, anxiety, sedation, insomnia, somnolence, and headache 2. Weight gain ≥7% of baseline occurred in 17.8% of patients 2.

Peak-to-trough fluctuation is greater with 4-week dosing intervals compared to 2-week intervals, though no apparent clinical ramifications have been identified for these differences 3.

References

3
Research

Pharmacokinetics of olanzapine long-acting injection: the clinical perspective.

International clinical psychopharmacology, 2014

Related Questions

What are the indications, recommended dosing, contraindications, and monitoring guidelines for olanzapine in adults?
What laboratory monitoring is recommended for a patient initiating olanzapine therapy?
Is olanzapine 10 mg once daily appropriate as the sole initial management?
What are the recommended strategies to manage olanzapine‑induced weight gain?
What are the recommended doses and frequency of Olanzapine (Zyprexa) depot injections?
What are the top differential diagnoses for a blanchable, pruritic, occasionally burning rash that began on the dorsum of the hands, spread to the elbows, chest, and eventually the entire body without fever?
When should routine HPV testing for cervical cancer screening be started, and are there any risk factors that would warrant earlier testing?
Is it appropriate to prescribe zolpidem 10 mg, limited to seven tablets per month, for an adult patient?
Are nocturnal emissions a normal physiologic phenomenon in males, and when should they be evaluated or treated?
What is the recommended management for a subdural hematoma measuring 3 mm on the right convexity and 4 mm on the right anterior falx?
What is the best antibiotic for a 68-year-old patient with a urinary tract infection, a penicillin allergy, and unknown renal function?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question